Correction of dysfunctional fatty acid metabolism using peroxisome proliferator activated receptor gamma agonists.
Oakes
Nicholas D
ND
AstraZeneca R&D Mölndal, S-431 82 Mölndal, Sweden. Nick.Oakes@astrazeneca.com
Ljung
Bengt
B
Camejo
Germán
G
D000273:Adipose Tissue / Q000378:metabolism; D000818:Animals; D001161:Arteriosclerosis / Q000209:etiology* / Q000378:metabolism; D005227:Fatty Acids / Q000378:metabolism*; D006801:Humans; D020025:Peroxisome Proliferators / Q000378:metabolism; D018160:Receptors, Cytoplasmic and Nuclear / Q000378:metabolism*; D014157:Transcription Factors / Q000378:metabolism*
D005227:Fatty Acids; D020025:Peroxisome Proliferators; D018160:Receptors, Cytoplasmic and Nuclear; D014157:Transcription Factors